| The treatment cascade for chronic hepatitis C virus infection in the United States: a systematic review and meta-analysis BR Yehia, AJ Schranz, CA Umscheid, V Lo Re III PloS one 9 (7), e101554, 2014 | 513 | 2014 |
| Hepatitis C guidance 2018 update: AASLD-IDSA recommendations for testing, managing, and treating hepatitis C virus infection AIHCVG Panel Clinical infectious diseases: an official publication of the Infectious …, 2018 | 330 | 2018 |
| Hepatic decompensation in antiretroviral-treated patients co-infected with HIV and hepatitis C virus compared with hepatitis C Virus–monoinfected patients: a cohort study VL Re III, MJ Kallan, JP Tate, AR Localio, JK Lim, MB Goetz, MB Klein, ... Annals of internal medicine 160 (6), 369-379, 2014 | 323 | 2014 |
| Patterns of COVID-19 testing and mortality by race and ethnicity among United States veterans: A nationwide cohort study CT Rentsch, F Kidwai-Khan, JP Tate, LS Park, JT King Jr, M Skanderson, ... PLoS medicine 17 (9), e1003379, 2020 | 316 | 2020 |
| A simple, dynamic measure of antiretroviral therapy adherence predicts failure to maintain HIV-1 suppression R Gross, B Yip, VL Re III, E Wood, CS Alexander, PR Harrigan, ... The Journal of infectious diseases 194 (8), 1108-1114, 2006 | 242 | 2006 |
| HCV epidemiology in high-risk groups and the risk of reinfection H Midgard, A Weir, N Palmateer, VL Re III, JA Pineda, J Macías, ... Journal of hepatology 65 (1), S33-S45, 2016 | 236 | 2016 |
| Eosinophilic meningitis VL Re III, SJ Gluckman The American journal of medicine 114 (3), 217-223, 2003 | 201 | 2003 |
| The short‐term incidence of hepatocellular carcinoma is not increased after hepatitis C treatment with direct‐acting antivirals: An ERCHIVES study DK Li, Y Ren, DS Fierer, S Rutledge, OS Shaikh, VL Re III, T Simon, ... Hepatology 67 (6), 2244-2253, 2018 | 177 | 2018 |
| Covid-19 testing, hospital admission, and intensive care among 2,026,227 United States veterans aged 54–75 years CT Rentsch, F Kidwai-Khan, JP Tate, LS Park, JT King Jr, M Skanderson, ... MedRxiv, 2020 | 171 | 2020 |
| Validation of three coding algorithms to identify patients with end‐stage liver disease in an administrative database D Goldberg, JD Lewis, SD Halpern, M Weiner, V Lo Re III Pharmacoepidemiology and drug safety 21 (7), 765-769, 2012 | 167 | 2012 |
| Validity of diagnostic codes and liver‐related laboratory abnormalities to identify hepatic decompensation events in the Veterans Aging Cohort Study VL Re III, JK Lim, MB Goetz, J Tate, H Bathulapalli, MB Klein, D Rimland, ... Pharmacoepidemiology and drug safety 20 (7), 689-699, 2011 | 161 | 2011 |
| Disparities in absolute denial of modern hepatitis C therapy by type of insurance VL Re III, C Gowda, PN Urick, JT Halladay, A Binkley, DM Carbonari, ... Clinical Gastroenterology and Hepatology 14 (7), 1035-1043, 2016 | 152 | 2016 |
| Contributions of traditional and HIV-related risk factors on non-AIDS-defining cancer, myocardial infarction, and end-stage liver and renal diseases in adults with HIV in the … KN Althoff, KA Gebo, RD Moore, CM Boyd, AC Justice, C Wong, ... The lancet HIV 6 (2), e93-e104, 2019 | 135 | 2019 |
| The Yale cTAKES extensions for document classification: architecture and application V Garla, VL Re III, Z Dorey-Stein, F Kidwai, M Scotch, J Womack, A Justice, ... Journal of the American Medical Informatics Association 18 (5), 614-620, 2011 | 125 | 2011 |
| Population-representative incidence of drug-induced acute liver failure based on an analysis of an integrated health care system DS Goldberg, KA Forde, DM Carbonari, JD Lewis, KBF Leidl, KR Reddy, ... Gastroenterology 148 (7), 1353-1361. e3, 2015 | 123 | 2015 |
| National Psoriasis Foundation COVID-19 Task Force guidance for management of psoriatic disease during the pandemic: Version 2—Advances in psoriatic disease management, COVID … JM Gelfand, AW Armstrong, S Bell, GL Anesi, A Blauvelt, C Calabrese, ... Journal of the American Academy of Dermatology 84 (5), 1254-1268, 2021 | 120 | 2021 |
| Covid-19 by race and ethnicity: a national cohort study of 6 million United States veterans CT Rentsch, F Kidwai-Khan, JP Tate, LS Park, JT King Jr, M Skanderson, ... MedRxiv, 2020 | 120 | 2020 |
| Risk of end-stage liver disease in HIV-viral hepatitis coinfected persons in North America from the early to modern antiretroviral therapy eras MB Klein, KN Althoff, Y Jing, B Lau, M Kitahata, V Lo Re III, GD Kirk, ... Clinical Infectious Diseases 63 (9), 1160-1167, 2016 | 117 | 2016 |
| Prevalence and risk factors for significant liver fibrosis among HIV-monoinfected patients M DallaPiazza, VK Amorosa, R Localio, JR Kostman, V Lo Re BMC infectious diseases 10, 1-7, 2010 | 117 | 2010 |
| Nonantiretroviral polypharmacy and adverse health outcomes among HIV-infected and uninfected individuals AC Justice, KS Gordon, M Skanderson, EJ Edelman, KM Akgün, ... Aids 32 (6), 739-749, 2018 | 97 | 2018 |
